Diabetes isn’t just about high blood sugar; it can cause strange symptoms like dark skin patches (acanthosis nigricans), ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...
In a healthcare industry that has become inundated with physicians who overprescribe pain medication and are all too eager to ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...
The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...